GelSana’s Post

🌟 Dive into the world of Fecal Microbiota Transplantation (FMT) with our latest article in the July BEAT eMag! Discover how, when, and why this medical procedure is making waves. Check out insights from Dr. Linda Toresson, PhD here: https://lnkd.in/gHnwUx35 💡 #FMT #MedicalInnovation #HealthcareResearch

How does the recovery of #canine corneal ulcers compare when treated with corneoconjunctival transposition (CCT) vs. conjunctival autografts (CA)? 🐕 👀 First-time insights on healing dynamics and inflammation response! #VET #dog #VetResearch Read it here 👇 😁 ： https://lnkd.in/dVEz4A-t

ISCCa's brief: What is biomineralization and the relationships between bones and the cardiovascular tissues ??? Biomineralization refers to the deposition of minerals onto an extracellular matrix, which can be either physiological, as in bone formation, or pathological, as in arterial medial calcification (AMC). Bone formation involves osteoblasts creating a collagen-rich matrix that becomes mineralized with hydroxyapatite. AMC, on the other hand, is the abnormal deposition of minerals within arterial walls, leading to increased vessel stiffness and reduced blood flow, commonly occurring in aging, diabetes, and chronic kidney disease (CKD). Although AMC shares some processes with bone mineralization, such as the involvement of vascular smooth muscle cells (VSMCs) that adopt osteoblast-like characteristics, key differences remain. AMC involves unique factors like increased apoptosis and specific reactions to environmental stressors. Understanding these differences is crucial for developing treatments for AMC that do not negatively impact bone health, as no current drugs effectively treat or reverse AMC. Join us for this hot topic by our expert Pr Isabel Orriss (Royal Veterinary College)

New publication! We recently published a retrospective study in JAVMA on the outcome of dental abscesses in pet rabbits. The results show that a previously reported minimal invasive abscess-packing technique has a high success rate. Pathogenic anaerobic and Gram-negative aerobic bacteria play a significant role in these abscesses, which should be considered when choosing antibiotics for systemic and local treatment. https://lnkd.in/grGgjcdY

Case Study: Managing Golden Retriever-Associated Uveitis and Glaucoma Golden Retriever-Associated Uveitis (GRAU), also known as pigmentary uveitis, is a chronic and hereditary eye condition unique to Golden Retrievers. Recently, I encountered a challenging case that emphasized the importance of early diagnosis, effective treatment, and prevention to ensure the best outcomes. The Case A 7-year-old Golden Retriever presented with: Persistent tearing (epiphora) and eye redness (episcleral injection). Cloudy appearance in the eyes due to corneal edema and pigment deposition. Blepharospasm (squinting) and signs of discomfort. Elevated intraocular pressure (IOP) on tonometry (>30 mmHg). Diagnostics Slit-Lamp Examination: Detected aqueous flare and pigment deposits on the cornea. Tonometry: Confirmed glaucoma with elevated IOP. Ultrasound Imaging: Identified posterior segment changes and early lens opacity. Treatment Protocol Medical Management: Anti-inflammatory Therapy: Prednisolone acetate 1% eye drops (1 drop every 6–8 hours). IOP Control: Timolol 0.5% eye drops (1 drop every 12 hours) and Dorzolamide 2% (1 drop every 8 hours). Pain Management: Gabapentin (10 mg/kg orally every 12 hours). Surgical Intervention: Planned for laser cyclophotocoagulation to control aqueous humor production, reducing IOP long-term. Outcome With consistent treatment, the dog's condition stabilized. Intraocular pressure normalized, and inflammation subsided, improving comfort and vision. Prevention and Client Education Regular Eye Exams: Advised routine IOP monitoring and annual eye checks for at-risk breeds. Genetic Awareness: Educated on avoiding breeding dogs with GRAU history. Early Intervention: Highlighted the importance of seeking veterinary care for early signs of redness, squinting, or tearing. Golden Retrievers are a beloved breed, but they are prone to unique health challenges. With early diagnosis, aggressive treatment, and client education, we can improve outcomes and preserve their quality of life. Have you managed a challenging case of uveitis or glaucoma in your practice? Share your insights in the comments! 🩺🐾 #VeterinaryMedicine #GoldenRetriever #Uveitis #Glaucoma #AnimalCare #CaseStudy

HDVI's precision at 300 to 600 microns allows us to penetrate the complexities of brain disorders that often go undetected with traditional imaging like CT and MRI. This technology is particularly vital when dealing with elusive brain masses that lack a blood supply, necessitating the use of MRI for about 20% of cases. For instance, Hunter, an 11-year-old Labrador, exhibited symptoms that antibiotics couldn't resolve. HDVI revealed an aggressive mass in his nasal cavity, extending into the brain, offering clarity where traditional methods fell short. Similarly, Jiggy, a 10-year-old Frenchie with chronic rhinitis and recent seizures, was found to have significant nasal bone degradation and a critical brain nodule thanks to HDVI's detailed imaging. Despite the rarity of brain cases, they present a lucrative niche in veterinary practice, with each scan generating substantial revenue, enhancing both diagnostic capabilities and financial performance. Practices can expect to handle two brain cases per quarter, each contributing significantly to the bottom line. Advance your diagnostic accuracy—subscribe to "Elevate and Expand your Practice with CT" Newsletter to get the full story.

What's new in the research when it comes to Intra-articular Injections for osteoarthritis in dogs? Here's a snippet of studies I've found! https://lnkd.in/gmWPBwse #fourleg #caninerehab #caninephysio

3 fundamental considerations about DIC - Disseminated Intravascular Coagulation: 🔹DIC is a complication of numerous inflammatory and neoplastic diseases 🔹The severity of DIC, and therefore its management, is directly proportional to the severity of the triggering pathology 🔹 The real therapy for DIC depends on its triggering cause All targeted therapies for coagulopathy, such as heparin, are inevitably only supportive, but never winning, if the triggering cause is not eliminated CASE: In the presence of a splenic hemangiosarcoma, it's common to observe coagulation activation, but there is no effective therapy (such as heparin) unless the cause is removed (splenectomy) #sharethevet #sanmarcovet #veterinarymedicine #vet

[Free Webinar Next Tuesday] Register Now: https://hubs.ly/Q02yCVmk0 As a clinically proven therapy, PRP (platelet-rich plasma) has the ability to treat numerous orthopedic and soft tissue conditions, as the majority of patients benefit from improved articular function, decreased inflammation, and regeneration of the damaged tissues. Join Dr. John Mather on Tuesday, June 11, for an overview on how this emerging modality can benefit your patients, your clients, and your practice. Dr. Mather will review the technology, reference studies, injection guidelines, his own real-world clinical cases, and the business case for adopting the modality into your practice. Learning Objectives -Mode of action and clinical applications for PRP -Differences between PRP systems with evidence -Benefits to the patient and the owner of using this system -The financial case for the use of PRP with real case studies #RegenerativeMedicine #Enovis #CompanionAnimalHealth #PlateletRichPlasma #VeterinaryEducation #VetMed #VetTech #BetterIs #VeterinaryPractice #VeterinaryModality #BetterPets #PRP #RegenerativeTherapy #VeterinaryWebinar #FreeWebinar

At Likarda, we're dedicated to developing groundbreaking solutions for some of the most persistent medical challenges. Our innovative platform is specifically designed to foster the creation of novel therapies, and diabetes is one treatment area our team has seen substantial breakthroughs. Leveraging one of our durable hydrogel formulations, we encapsulated insulin-producing cells derived from human stem cells. This innovative approach allows these cells to be infused into the abdomen of dogs suffering from diabetes, where they naturally detect blood glucose levels and release insulin—eliminating the need for daily injections. Without this encapsulation, the human cells would likely be destroyed by the dog's immune system within weeks. But with our hydrogel technology, we protect and sustain these cells, offering a potential long-term solution to diabetes management in canines. We're excited about the potential this breakthrough holds—not just for veterinary medicine but for broader medical applications. At Likarda, we're pushing the boundaries of what's possible, developing new therapies that have the power to change lives. Learn more about what our innovative solutions are capable of: https://lnkd.in/gH2XEEdC #caninehealth #diabetes #diabetestreatment #heathcareinnovation #animalhealth